載入...
CRISPR/Cas9 targeting of the androgen receptor suppresses the growth of LNCaP human prostate cancer cells
Androgens have been recognized to be primary causative agents of prostate cancer. Following binding to the androgen receptor (AR), androgens serve important roles in the carcinogenesis of prostate cancers. ARs serve an important role during all stages of prostate cancer, and inhibiting their functio...
Na minha lista:
| 發表在: | Mol Med Rep |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5783506/ https://ncbi.nlm.nih.gov/pubmed/29257308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.8257 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|